Matthew Cagliostro is a Cardiology physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 19 publications with 359 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1190 5th Ave
New York, NY 100296503
Telephone
212-427-1540Provider last certified this registry record 3 Aug 2023.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CVRx, Inc.Program year20255 payments
- Abbott LaboratoriesProgram year20254 payments
- ABIOMEDProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
68.1%Aldosterone antagonist (MRA)14.6%Spironolactone87%Eplerenone13%Part D<11 patientsLoop diuretic13.9%Torsemide60%Furosemide40%Part D≥13 patients+ 6 more classes in this area
Metabolism & gastrointestinal
21.3%SGLT2 inhibitor13.7%Jardiance65%Farxiga35%Part D<11 patientsProton pump inhibitor4.9%Pantoprazole Sodium56%Omeprazole44%Part D<11 patients+ 1 more class in this area
Blood & clotting
6%Factor Xa inhibitor4%Eliquis100%Part D<11 patientsVitamin K antagonist2%Warfarin Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-CCC-16147-ACC A CASE OF FULMINANT GIANT CELL MYOCARDITIS: THE CHALLENGE OF DIAGNOSTIC UNCERTAINTY
Journal of the American College of Cardiology
2026 - Complement Activation in Early Endomyocardial Biopsies Following Ex-Vivo Perfusion
The Journal of Heart and Lung Transplantation
2025 - Management of Threatened Pump Thrombosis with Heartmate II LVAD with Central Apposition Suture: Complex Decision Making and a Clinical Refresher
The Journal of Heart and Lung Transplantation
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”